Lessons from Fragile X Regarding Neurobiology, Autism, and Neurodegeneration
- 1 February 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Developmental & Behavioral Pediatrics
- Vol. 27 (1) , 63-74
- https://doi.org/10.1097/00004703-200602000-00012
Abstract
The fragile X mental retardation 1 gene (FMR1) mutation causes two disorders: fragile X syndrome (FXS) in those with the full mutation and the fragile X-associated tremor/ataxia syndrome (FXTAS) in some older individuals with the premutation. FXS is caused by a deficiency of the FMR1 protein (FMRP) leading to dysregulation of many genes that create a phenotype with ADHD, anxiety, and autism. FXTAS is caused by the elevation of FMR1-mRNA to levels 2 to 8 times normal in the premutation. This causes an RNA gain of function toxicity leading to brain atrophy, white matter disease, neuronal and astrocytic inclusion formation, and subsequent ataxia, intention tremor, peripheral neuropathy, and cognitive decline. The neurobiology and pathophysiology of FXS and FXTAS are described in detail.Keywords
This publication has 142 references indexed in Scilit:
- Pharmacological Rescue of Synaptic Plasticity, Courtship Behavior, and Mushroom Body Defects in a Drosophila Model of Fragile X SyndromeNeuron, 2005
- The mGluR theory of fragile X mental retardationPublished by Elsevier ,2004
- Psychopharmacology in fragile X syndrome—Present and futureMental Retardation and Developmental Disabilities Research Reviews, 2004
- Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout miceMolecular Psychiatry, 2004
- Social behavior profile in young males with fragile X syndrome: Characteristics and specificityAmerican Journal of Medical Genetics Part A, 2004
- Relationship of deficits of FMR1 gene specific protein with physical phenotype of fragile X males and females in pedigrees: A new perspectiveAmerican Journal of Medical Genetics Part A, 2002
- Influence of stimulants on electrodermal studies in Fragile X syndromeMicroscopy Research and Technique, 2002
- Molecular‐neurobehavioral associations in females with the fragile X full mutationAmerican Journal of Medical Genetics, 1994
- Population screening for fragile XThe Lancet, 1992
- A controlled trial of stimulant medication in children with the fragile X syndromeAmerican Journal of Medical Genetics, 1988